Stay updated on Teplizumab in Pediatric Stage 2 Type 1 Diabetes Clinical Trial
Sign up to get notified when there's something new on the Teplizumab in Pediatric Stage 2 Type 1 Diabetes Clinical Trial page.

Latest updates to the Teplizumab in Pediatric Stage 2 Type 1 Diabetes Clinical Trial page
- Check4 days agoNo Change Detected
- Check12 days agoNo Change Detected
- Check19 days agoChange DetectedThe page has removed a notice regarding heavy traffic affecting the performance and availability of some NLM-NCBI services and products.SummaryDifference5%
- Check33 days agoNo Change Detected
- Check40 days agoChange DetectedThe page now includes a notice about heavy traffic affecting the performance and availability of some NLM-NCBI services and products, along with a contact email for assistance.SummaryDifference6%
- Check47 days agoChange DetectedThe website has been updated from version v2.14.1 to v2.14.2.SummaryDifference0.3%
- Check62 days agoChange DetectedThe website has been updated from version 2.14.0 to 2.14.1.SummaryDifference0.3%
- Check69 days agoChange DetectedThe website has updated the 'type of intervention' feature from version v2.13.3 to v2.14.0, indicating a significant change in this aspect.SummaryDifference1.0%
- Check98 days agoChange DetectedThe website has been updated from version 2.13.2 to 2.13.3.SummaryDifference0.3%
Stay in the know with updates to Teplizumab in Pediatric Stage 2 Type 1 Diabetes Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Teplizumab in Pediatric Stage 2 Type 1 Diabetes Clinical Trial page.